• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of therapy for cancer stem cell targeting miRNA in esophageal squamous cell carcinoma

Research Project

Project/Area Number 26461996
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Digestive surgery
Research InstitutionKeio University

Principal Investigator

Fukuda Kazumasa  慶應義塾大学, 医学部(信濃町), 特任講師 (50348786)

Project Period (FY) 2014-04-01 – 2017-03-31
Project Status Completed (Fiscal Year 2016)
Budget Amount *help
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2016: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
KeywordsmiRNA / 食道癌 / 癌幹細胞 / 食道癌幹細胞
Outline of Final Research Achievements

In the present study, we investigated miRNA expression profile and function in CSC-like clones and serum derived from esophageal squamous cell carcinoma (ESCC) patients. The result exhibited common 67 miRNAs differentially expressed between CSC-like clones and their parent cell lines. The genes predicted to be targets of candidate miRNAs were chosen and analyzed using the database of miRNA.org site. miR-125a-5p has important roles in docetaxel resistance by regulating protein expression of the ICIS gene. Analysis of comprehensive expression of miRNA in serum was performed using the 3D-Gene system. Between lymph node metastasis group and non-metastasis group, 33 miRNAs significantly showed expression fluctuation. These findings suggest that it may be helpful to develop novel strategies for targeted therapies in ESCC patients.

Report

(4 results)
  • 2016 Annual Research Report   Final Research Report ( PDF )
  • 2015 Research-status Report
  • 2014 Research-status Report

URL: 

Published: 2014-04-04   Modified: 2018-03-22  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi